Intelligent Bio Solutions Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Harry Simeonidis, with a market cap of $5.1M.
Common questions about Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. is scheduled to report earnings for Q3 2026 on May 12, 2026.
Intelligent Bio Solutions Inc. has approximately 51 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.